Trials / Unknown
UnknownNCT02264301
Qingkailing Injection Versus Puerarin Injection on Withdrawal Rate of Corticosteroids in Patients With Active Rheumatoid Arthritis
The Effect of Qingkailing Injection on Corticosteroids Withdrawal Rate in Patients With Active Rheumatoid Arthritis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- Sponsor
- Chengdu PLA General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of Qingkailing injection versus Puerarin injection on withdrawal rate of corticosteroids in patients with active rheumatoid arthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Puerarin injection 400 mg | |
| DRUG | Qingkailing injection 40 ml |
Timeline
- Start date
- 2014-08-01
- Primary completion
- 2017-12-01
- Completion
- 2017-12-01
- First posted
- 2014-10-15
- Last updated
- 2017-04-04
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02264301. Inclusion in this directory is not an endorsement.